4HJ0
Crystal structure of the human GIPr ECD in complex with Gipg013 Fab at 3-A resolution
4HJ0 の概要
| エントリーDOI | 10.2210/pdb4hj0/pdb |
| 分子名称 | Gastric inhibitory polypeptide receptor, Gipg013 Fab, Antagonizing antibody to the GIP Receptor, Heavy chain, Gipg013 Fab, Antagonizing antibody to the GIP Receptor, Light chain (3 entities in total) |
| 機能のキーワード | glucagon receptor sub-family recognition fold, immune system |
| 由来する生物種 | Homo sapiens (human) 詳細 |
| 細胞内の位置 | Cell membrane; Multi-pass membrane protein: P48546 |
| タンパク質・核酸の鎖数 | 6 |
| 化学式量合計 | 124429.64 |
| 構造登録者 | Madhurantakam, C.,Ravn, P.,Gruetter, M.G.,Jackson, R.H. (登録日: 2012-10-12, 公開日: 2013-05-29, 最終更新日: 2024-11-20) |
| 主引用文献 | Ravn, P.,Madhurantakam, C.,Kunze, S.,Matthews, E.,Priest, C.,O'Brien, S.,Collinson, A.,Papworth, M.,Fritsch-Fredin, M.,Jermutus, L.,Benthem, L.,Gruetter, M.,Jackson, R.H. Structural and Pharmacological Characterization of Novel Potent and Selective Monoclonal Antibody Antagonists of Glucose-dependent Insulinotropic Polypeptide Receptor. J.Biol.Chem., 288:19760-19772, 2013 Cited by PubMed Abstract: Glucose-dependent insulinotropic polypeptide (GIP) is an endogenous hormonal factor (incretin) that, upon binding to its receptor (GIPr; a class B G-protein-coupled receptor), stimulates insulin secretion by beta cells in the pancreas. There has been a lack of potent inhibitors of the GIPr with prolonged in vivo exposure to support studies on GIP biology. Here we describe the generation of an antagonizing antibody to the GIPr, using phage and ribosome display libraries. Gipg013 is a specific competitive antagonist with equally high potencies to mouse, rat, dog, and human GIP receptors with a Ki of 7 nm for the human GIPr. Gipg013 antagonizes the GIP receptor and inhibits GIP-induced insulin secretion in vitro and in vivo. A crystal structure of Gipg013 Fab in complex with the human GIPr extracellular domain (ECD) shows that the antibody binds through a series of hydrogen bonds from the complementarity-determining regions of Gipg013 Fab to the N-terminal α-helix of GIPr ECD as well as to residues around its highly conserved glucagon receptor subfamily recognition fold. The antibody epitope overlaps with the GIP binding site on the GIPr ECD, ensuring competitive antagonism of the receptor. This well characterized antagonizing antibody to the GIPr will be useful as a tool to further understand the biological roles of GIP. PubMed: 23689510DOI: 10.1074/jbc.M112.426288 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (3 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






